A $9.7 Billion deal was put forth by Novartis AG to purchase a US biotech firm The Medicines Co. For enlarging its medication portfolio, the…
A $9.7 Billion deal was put forth by Novartis AG to purchase a US biotech firm The Medicines Co. For enlarging its medication portfolio, the…